Skip to main content
. 2021 Jan 20;10:614455. doi: 10.3389/fonc.2020.614455

Table 3.

LINC00483 dysregulation in several expression datasets.

Dataset Class Expression P-value
GSE3629 (121) Class: colorectal cancer vs. non-neoplastic rectal mucosa Down in tumor 1.50E−19
GSE3629 (121) Group: sporadic ca vs. uc-nonca Down in sporadic ca 1.50E−17
GSE21510 (148) Tissue: cancer-lcm vs. normal-homogenized Down in cancer 5.80E−16
GSE8671 (64) Tissue: adenoma vs. normal Down in adenoma 4.70E−10
GSE20916 (145) Tissue: adenocarcinoma vs. normal_colon Down in adenocarcinoma 1.20E−09
GSE3629 (121) Group: sporadic ca vs. uc-ca Down in sporadic ca 1.50E−09
GSE76124 (198) tumor_grade: poorly_differentiated vs. well_differentiated Down in poorly differentiated 5.70E−08
GSE20916 (145) Malignancy: carcinoma vs distant_normal_colon Down in carcinoma 4.50E−07
GSE8671 (64) nt_size: 0.2_cm_(x3) vs. 2.0_cm Down in 2 cm 4.60E−07
 GSE35896 (62) braf_mutation: n vs. y Down in y 5.30E−07
GSE8671 (64) nt_size: 0.2_cm_(x3) vs. 1.5_cm Down 1.5 cm 8.60E−07
GSE2109 (315) nt_pathological_grade: 2 vs. 3 Down in 3 3.10E−06
GSE39582 (566) cimp_status: neg vs. pos Down in pos 3.30E−06
 GSE35896 (62) braf_mutation: n vs. y Down in y 7.50E−06
GSE20916 (145) Tissue: carcinoma vs. normal_colon Down in carcinoma 1.90E−05
GSE6791 (84) sample_source: cervical normal vs.c head and neck cancer Down in cancer 1.90E−05
GSE6791 (84) Type: cervical normal vs. head and neck cancer Down in cancer 1.90E−05
GSE4554 (84) ms_status: msi vs. mss Down in msi 2.00E−05
GSE8671 (64) nt_location_tissue: sigmoid_colon_adenoma vs. sigmoid_colon_normal Down in adenoma 2.60E−05
GSE76124 (198) tumor_grade: moderately_differentiated vs. well_differentiated Down in moderately differentiated 3.80E−05
GSE23878 (59) Group: colon tumor vs. normal paired tissue Down in colon tumor 4.70E−05
GSE29271 (210) survival_time_(months): 35 vs. 9 Down in 35 5.60E−05
GSE20916 (145) Malignancy: adenoma vs. carcinoma Down in adenoma 6.10E−05
GSE13294 (155) microsatellite_status: msi vs. mss Down in msi 1.20E−04
GSE8671 (64) nt_location_tissue: descending_colon_adenoma vs. rectum_normal Down in adenoma 5.30E−04
GSE8671 (64) nt_location_tissue: descending_colon_adenoma vs. descending_colon_normal Down in adenoma 5.40E−04
GSE20916 (145) Tissue: colon_tumor vs. norma_colon Down in tumor 6.10E−04
GSE3629 (121) Group: uc-associated ca vs. uc-nonca Down in ca 6.90E−04
GSE41258 (390) Tissue: normal colon vs. polyp Down in polyp 2.20E−03
GSE17538 (232) ajcc_stage: 2 vs. 4 Down in 2 4.20E−03
GSE35896 (62) pten_mutation: n vs. y Down in y 4.20E−03
GSE29271 (210) survival_time_(months): 36 vs. 6 Down in 36 4.60E−03
GSE42363 (14) tumor_grade: moderately vs. poorly Down in poorly diffentiated 5.20E−03
GSE4183 (53) Group: colon_adenoma vs. healthy_control Down in adenoma 5.20E−03
GSE35896 (62) pten_mutation: n vs. y Down in y 5.40E−03
GSE50948 (156) invasive_tumor_area_size: 15 vs. 6 Down in 15 5.80E−03
GSE33114 (108) sample_descr: normal colon mucosa vs primary tumor resection Down in tumor 8.30E−03
GSE33114 (108) sample_source: normal colon mucosa vs. primary tumor resection Down in tumor 8.30E−03
GSE33114 (108) Type: normal vs. tumor Down in tumor 8.30E−03
GSE21510 (148) Tissue: cancer-homogenized vs. normal-homogenized Down in cancer 8.30E−03
GSE4107 (22) Tissue: mucosa_control vs. mucosa_patient Down in patients 8.60E−03
GSE9891 (285) Stagecode: ia vs. iii Down in ia 9.50E−03
GSE35896 (62) kras_mutation: n vs. y Down in no 9.60E−03
GSE17538  (232) ajcc_stage: 1 vs. 2 Down in 2 9.70E−03

In this table are reported 1) GEO ID (the sample number is shown in brackets); 2) class of comparison; 3) LINC00483 expression; 4) p-values of ANOVA test for each dataset.